New drug could help kidney transplant patients avoid rejection
Disease control
Recruiting now
This study tests if a new drug called siplizumab can safely prevent kidney transplant rejection better than the current standard treatment. About 120 adults receiving a kidney transplant will be split into three groups: two groups get different doses of siplizumab, and one gets t…
Phase: PHASE2 • Sponsor: Nefro Avillion Clinical Development, LLC • Aim: Disease control
Last updated Jul 02, 2026 07:00 UTC